Biological engineers discover new antibiotic candidates
Permalink

Biological engineers discover new antibiotic candidates

The human body produces many antimicrobial peptides that help the immune system fend off infection. Scientists hoping to harness these peptides as potential antibiotics have now discovered that…

Continue Reading →

Cutting to the chase – how a folded piece of paper is saving lives
Permalink

Cutting to the chase – how a folded piece of paper is saving lives

Around the world, many hundreds of millions of people are infected by parasitic diseases such as malaria and schistosomiasis. Many more millions of people are affected by the…

Continue Reading →

Patenting aerospace medicines – the final frontier?
Permalink

Patenting aerospace medicines – the final frontier?

Research and development (R&D) into aerospace medicine can be viewed as falling into one of two camps: that aimed at adapting an existing ‘terrestrial’ medicine for use in…

Continue Reading →

Know your third party patent rights
Permalink

Know your third party patent rights

In the competitive world of the biosciences, third party patent rights (TPRs) can stand in the way of a planned course of action, even after significant investment has…

Continue Reading →

The IP journey and risk mitigation
Permalink

The IP journey and risk mitigation

Paul Storer Senior Policy Adviser in the Business Support Policy Team at the IPO Resolving IP disputes can be costly and the Intellectual Property Office continues to seek…

Continue Reading →

The search for new antimicrobials
Permalink

The search for new antimicrobials

Few issues are more pressing than the global problem of antibiotic resistance, so we speak to Professor Mathew Upton, about his work searching for new antibiotics. “For so…

Continue Reading →

New research predicts a positive future for biosimilars
Permalink

New research predicts a positive future for biosimilars

The prospect of reducing treatment costs for payors supports a positive future for biosimilars Biosimilar approvals in the US market still significantly lag behind Europe despite an evolving…

Continue Reading →

A new way to manufacture small batches of biopharmaceuticals on demand
Permalink

A new way to manufacture small batches of biopharmaceuticals on demand

Biopharmaceuticals, a class of drugs comprising proteins such as antibodies and hormones, represent a fast-growing sector of the pharmaceutical industry. They’re increasingly important for “precision medicine” — drugs…

Continue Reading →

Making Pharmaceuticals person-specific
Permalink

Making Pharmaceuticals person-specific

Dr Mohammed Maniruzzaman: Lecturer in Pharmaceutics and Drug Delivery at the University of Sussex In this issue of BioScience Today, we speak to Dr Mohammed Maniruzzaman, Lecturer in Pharmaceutics and…

Continue Reading →

UK-led study marks shift towards genetic era in tackling TB
Permalink

UK-led study marks shift towards genetic era in tackling TB

In a landmark study that may herald a quicker, more tailored treatment for the millions of people around the world living with tuberculosis (TB), UK researchers have shown…

Continue Reading →

New ‘trap’ to analyse, in real time, how cells communicate
Permalink

New ‘trap’ to analyse, in real time, how cells communicate

Using multiple laser beams and Raman spectroscopy, experts at the Universities of Nottingham and Glasgow have designed and built a new instrument which could help scientists learn more…

Continue Reading →

Researchers discover how fatal biofilms form
Permalink

Researchers discover how fatal biofilms form

By severely curtailing the effects of antibiotics, the formation of organized communities of bacterial cells known as biofilms can be deadly during surgeries and in urinary tract infections.…

Continue Reading →

Discovery helps fight against drug-resistant Tuberculosis
Permalink

Discovery helps fight against drug-resistant Tuberculosis

A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis. Each year, approximately 10 million people fall ill with…

Continue Reading →

Using apprenticeships to build skills for innovation in life sciences
Permalink

Using apprenticeships to build skills for innovation in life sciences

Dr. Gillian Burgess, Site Head of UK Research and Vice President at Vertex Pharmaceuticals and Board Member of the Science Industry Partnership (SIP) of employers, sets out the business case…

Continue Reading →

Regulator protein key to malaria parasite’s lifecycle
Permalink

Regulator protein key to malaria parasite’s lifecycle

Malaria remains a significant threat to human health with approximately 216 million cases annually and over 400,000 deaths worldwide. It is caused by the Plasmodium parasite, which has…

Continue Reading →

Discovery aids disease elimination efforts
Permalink

Discovery aids disease elimination efforts

David Horn: Professor of Parasite Molecular Biology, University of Dundee Researchers at the University of Dundee have identified a new drug target in parasites that cause major neglected tropical…

Continue Reading →